C-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes

被引:69
作者
Dessauge, G
Hilaly, S
Baumgartner, M
Blumen, B
Werling, D
Langsley, G
机构
[1] Inst Pasteur, Dept Parasitol, CNRS URA CNRS 2581, Lab Signalisat Immunoparasitaire, F-75724 Paris 15, France
[2] Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA
[3] Royal Vet Coll, N Mymms AL9 7TA, Herts, England
关键词
apoptosis; c-Myc; STAT3; Theileria; transformation;
D O I
10.1038/sj.onc.1208314
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Theileria parasites infect and transform bovine lymphocytes, but host cell immortalization is reversible, as upon parasite death the lymphocytes rapidly die of apoptosis. Infection leads to a marked augmentation in the levels of lymphocyte c-Myc, and the parasite achieves this by inducing increased c-myc transcription and by prolonging the half-life of the transcription factor. Reduction in c-Myc turnover can be ascribed to CK2-mediated phosphorylation of the transcription factor. A parasite-dependent GM-CSF autocrine loop activates a JAK2/ STAT3 signalling pathway that contributes to heightened c-myc transcription, and inhibition of the pathway leads to caspase 9 activation and apoptosis that can be directly ascribed to a reduction in c-Myc. An antiapoptotic role for c-Myc was clearly demonstrated by specific inhibition of c-myc expression with antisense oligonucleotides, and this correlates with loss of the antiapoptotic protein Mcl-1, and, consistently, ectopic expression of c-Myc abrogates B-cell death induced upon JAK2 inhibition. Thus, Theileria parasites ensure the survival of their host lymphocytes via specific activation of c-Myc.
引用
收藏
页码:1075 / 1083
页数:9
相关论文
共 35 条
[21]   The platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway [J].
Iavarone, C ;
Catania, A ;
Marinissen, MJ ;
Visconti, R ;
Acunzo, M ;
Tarantino, C ;
Carlomagno, MS ;
Bruni, CB ;
Gutkind, JS ;
Chiariello, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50024-50030
[22]   STAT3 is required for the gp130-mediated full activation of the c-myc gene [J].
Kiuchi, N ;
Nakajima, K ;
Ichiba, M ;
Fukada, T ;
Narimatsu, M ;
Mizuno, K ;
Hibi, M ;
Hirano, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :63-73
[23]   Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis [J].
Küenzi, P ;
Schneider, P ;
Dobbelaere, DAE .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1224-1231
[24]   Myc requires distinct E2F activities to induce S phase and apoptosis [J].
Leone, G ;
Sears, R ;
Huang, E ;
Rempel, R ;
Nuckolls, F ;
Park, CH ;
Giangrande, P ;
Wu, LZ ;
Saavedra, HI ;
Field, SJ ;
Thompson, MA ;
Yang, HD ;
Fujiwara, Y ;
Greenberg, ME ;
Orkin, S ;
Smith, C ;
Nevins, JR .
MOLECULAR CELL, 2001, 8 (01) :105-113
[25]   Quantitative analysis of pro-inflammatory cytokine mRNA expression in Theileria annulata-infected cell lines derived from resistant and susceptible cattle [J].
McGuire, K ;
Manuja, A ;
Russell, GC ;
Springbett, A ;
Craigmile, SC ;
Nichani, AK ;
Malhotra, DV ;
Glass, EJ .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2004, 99 (1-2) :87-98
[26]   In vitro infection with Theileria parva is associated with IL10 expression in all bovine lymphocyte lineages [J].
McKeever, DJ ;
Nyanjui, JK ;
Ballingall, KT .
PARASITE IMMUNOLOGY, 1997, 19 (07) :319-324
[27]   Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor [J].
Meydan, N ;
Grunberger, T ;
Dadi, H ;
Shahar, M ;
Arpaia, E ;
Lapidot, Z ;
Leeder, JS ;
Freedman, M ;
Cohen, A ;
Gazit, A ;
Levitzki, A ;
Roifman, CM .
NATURE, 1996, 379 (6566) :645-648
[28]  
Moreau MF, 1999, INFECT IMMUN, V67, P6678
[29]   A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells [J].
Nakajima, K ;
Yamanaka, Y ;
Nakae, K ;
Kojima, H ;
Ichiba, M ;
Kiuchi, N ;
Kitaoka, T ;
Fukada, T ;
Hibi, M ;
Hirano, T .
EMBO JOURNAL, 1996, 15 (14) :3651-3658
[30]   Myc pathways provoking cell suicide and cancer [J].
Nilsson, JA ;
Cleveland, JL .
ONCOGENE, 2003, 22 (56) :9007-9021